Treatment with cisplatin combined with the protein vaccine induced a significant increase in tumor-infiltrating CD8+ T cells (Fig. 5B), particularly antigen-specific CD8+ T cells, compared with mice treated with the protein-based vaccine alone (Fig. 5C). Here, CD8A is linked to neoplasm.